MX9303764A - 5'-indoliniloxazolidinonas utiles contra mycobacterium tuberculosis fundamento de la invencion. - Google Patents

5'-indoliniloxazolidinonas utiles contra mycobacterium tuberculosis fundamento de la invencion.

Info

Publication number
MX9303764A
MX9303764A MX9303764A MX9303764A MX9303764A MX 9303764 A MX9303764 A MX 9303764A MX 9303764 A MX9303764 A MX 9303764A MX 9303764 A MX9303764 A MX 9303764A MX 9303764 A MX9303764 A MX 9303764A
Authority
MX
Mexico
Prior art keywords
indolinyloxazolidinones
basis
mycobacterium tuberculosis
useful against
against mycobacterium
Prior art date
Application number
MX9303764A
Other languages
English (en)
Spanish (es)
Inventor
Steven Josjeph Brickner
Gary Edward Zurenko
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MX9303764A publication Critical patent/MX9303764A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX9303764A 1992-07-08 1993-06-23 5'-indoliniloxazolidinonas utiles contra mycobacterium tuberculosis fundamento de la invencion. MX9303764A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90938792A 1992-07-08 1992-07-08

Publications (1)

Publication Number Publication Date
MX9303764A true MX9303764A (es) 1994-01-31

Family

ID=25427164

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9303764A MX9303764A (es) 1992-07-08 1993-06-23 5'-indoliniloxazolidinonas utiles contra mycobacterium tuberculosis fundamento de la invencion.

Country Status (9)

Country Link
EP (1) EP0648119A1 (enrdf_load_html_response)
JP (1) JPH07508985A (enrdf_load_html_response)
KR (1) KR950702417A (enrdf_load_html_response)
AU (1) AU666740B2 (enrdf_load_html_response)
CA (1) CA2136324A1 (enrdf_load_html_response)
IL (1) IL106220A0 (enrdf_load_html_response)
MX (1) MX9303764A (enrdf_load_html_response)
TW (1) TW260608B (enrdf_load_html_response)
WO (1) WO1994001110A1 (enrdf_load_html_response)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
GB9702213D0 (en) 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
BR9910971A (pt) 1998-06-05 2001-02-13 Astrazeneca Ab Composto, processos para a preparação de um composto e para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto, e, composição farmacêutica
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
MXPA05001558A (es) 2002-08-12 2005-09-08 Pharmacia & Upjohn Co Llc N-aril-2-oxazolidinonas y sus derivados.
EP1565186B1 (en) 2002-11-21 2006-11-02 Pharmacia & Upjohn Company LLC N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
IL299155A (en) 2020-06-18 2023-02-01 Akagera Medicines Inc Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5314792A (en) * 1976-07-24 1978-02-09 Rubuobuna Buratsurabusukay Ara Copolymers of nnvinylmethylpyrazol and diivinyl crossslinking agent and process for producing same
JPS54110186A (en) * 1978-02-17 1979-08-29 Tokyo Yuuki Kagaku Kougiyou Kk Method of mamufacturing weak basic anion exchange resin
DE3324835A1 (de) * 1983-07-09 1985-01-17 Cassella Ag, 6000 Frankfurt Vernetztes copolymerisat, verfahren zu seiner herstellung und seine verwendung als sorptionsmittel
JPS6023854A (ja) * 1983-07-19 1985-02-06 Konishiroku Photo Ind Co Ltd 写真要素
DE3434137A1 (de) * 1984-09-18 1986-03-20 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von unloeslichen, nur wenig quellbaren pulverfoermigen polymeren
JPS63130605A (ja) * 1986-11-20 1988-06-02 Tokuyama Soda Co Ltd 陰イオン交換体の製造方法
US4889632A (en) * 1987-12-10 1989-12-26 Ceskoslovenska Akademie Ved Macroporous polymeric membranes for the separation of polymers and a method of their application
EP0434714A1 (en) * 1988-09-15 1991-07-03 The Upjohn Company In position 3 substituted-5-beta-amidomethyl-oxazolidin-2-ones
GB8829835D0 (en) * 1988-12-21 1989-02-15 Smith Kline French Lab Compounds
JPH03708A (ja) * 1989-05-29 1991-01-07 Koei Chem Co Ltd 吸水性材料

Also Published As

Publication number Publication date
WO1994001110A1 (en) 1994-01-20
EP0648119A1 (en) 1995-04-19
KR950702417A (ko) 1995-07-29
TW260608B (enrdf_load_html_response) 1995-10-21
AU4386593A (en) 1994-01-31
JPH07508985A (ja) 1995-10-05
AU666740B2 (en) 1996-02-22
IL106220A0 (en) 1993-11-15
CA2136324A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
MX9303764A (es) 5'-indoliniloxazolidinonas utiles contra mycobacterium tuberculosis fundamento de la invencion.
MX9202279A (es) Combinaciones de agentes antivirales.
ES2128669T3 (es) Metodo para el tratamiento de la ansiedad usando un compuesto de tetrahidropiridina u oxadiazol o tiadiazol azabiciclico.
DE59400489D1 (de) Fungizide Wirkstoffkombinationen
ES2116801T3 (es) Empleo de derivados de adamantano para el tratamiento de tinnitus.
SE7903186L (sv) Cerebralverksamt medel
PT85055A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ester metilico da levodopa
ES2079320B1 (es) Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
DK0659410T3 (da) Anvendelse af det aktive middel flupirtin til fremstilling af et lægemiddel til bekæmpelse af muskelspændinger
IL128877A0 (en) Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
ES2103928T5 (es) Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis.
DK0415613T3 (da) Anvendelse af sertralin til behandling af præmatur ejakulation
FI923357A0 (fi) Framstaellning av fettsyramediciner.
ES2053748T3 (es) Oxazoles y tiazoles para el tratamiento de la demencia senil.
DK164441C (da) Anvendelse af et piperidinderivat til fremstilling af et farmaceutisk praeparat til behandling af smertetilstande
ES2074191T3 (es) Oxazolidinonas.
BR9811319A (pt) Método para proteger um animal contra umadoença crÈnica
AR031032A1 (es) Uso de la tolterodina en el tratamiento del asma
PT1096934E (pt) Oxazolidinonas para tratamento de infeccoes oculares
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
PT1147105E (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente activo e sua utilizacao no tratamento de doencas vasculares
ES2191763T3 (es) Inhibidor del desarrollo de dependencia/tolerancia a un agente analgesico narcotico.
DK0435177T3 (da) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler
ES2085665T3 (es) Agente neuroprotector.
DK730488D0 (da) Synergistisk kombination af decarboxylasehaemmere og l-dopa-pellets